HopeStage
Back to all studies
RecruitingNCT06129890

TMS targets for neuropathic pain and depression: motor or prefrontal cortex

About this titleRead the official source — NCT06129890
Device studyAges 18–85France
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.

Listed locations
Saint-EtienneSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 26, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 85 Years
Official registry ID
NCT06129890
Official title
Show the full official title

Neuromodulation in Patients With Neuropathic Pain and Depression: a Cross-over Study Between Two Targets in Transcranial Magnetic Stimulation, the Primary Motor Cortex and the Dorsolateral Prefrontal Cortex.

Recruitment & locations

Currently recruiting

Saint-Etienne

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre Hospitalier Universitaire de Saint Etienne.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies